ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1712

The Lymph Node Microenvironment in SLE Mice Is Altered and Impairs Egress of T Lymphocytes

Mir Howlader1, Audrey Baeyens2, Susan Schwab2 and theresa Lu3, 1Weill Cornell Medical College, Brooklyn, NY, 2New York University Grossman School of Medicine, New York, NY, 3Hospital for Special Surgery, New York, NY

Meeting: ACR Convergence 2022

Keywords: Mouse Models, Lupus

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2022

Title: SLE – Animal Models Poster

Session Type: Poster Session D

Session Time: 1:00PM-3:00PM

Background/Purpose: T cell entry into and exit from lymph nodes (LNs) exposes T cells to antigens/cytokines required for their activation and regulates the nature of the T cell immune response. However, T cell trafficking through lymphoid tissues in SLE has not been explored. Impaired T cell exit means prolonged exposure to antigen-presenting cells which may lead to increased production of autoantibodies and contribute to disease pathogenesis. Lymphopenia and lymphadenopathy in SLE suggests that there is a disruption in lymphocyte trafficking where lymphocytes are being kept out of circulation and potentially being held in LNs. Egress of T cells from LNs is carefully regulated by the LN microenvironment. A low sphingosine-1-phosphate (S1P) concentration in the LN maintains S1P receptor 1 (S1PR1) expression on T cells which promotes egress by overriding CCR7/CCL21 retention signals. Here, we hypothesize that the LN microenvironment is altered in SLE and contributes to impaired egress of T cells. In this study, we investigate egress of T cells and then delineate a potential mechanism behind changes to egress in SLE.

Methods: We used an inducible lupus mouse model (B6 IMQ) where mice receive topical applications of imiquimod, a TLR7 agonist that produces a high Type 1 interferon signature also present in SLE. To determine if the LN microenvironment affects egress, CFSE labeled naive T cells were intravenously (i.v) injected into the B6 IMQ mice. Egress was assessed by comparing the number of T cells remaining in a LN after blocking their entry with anti-L-selectin to their numbers pre-blockade. S1PR1 expression was used as a readout of S1P levels as S1PR1 is internalized in the presence of high S1P. CD69 can also internalize S1PR1 through physical association and to assess for this, T cells from CD69 knock-out (KO) mice were injected i.v into B6 IMQ. Flow cytometry was performed on skin draining LNs to identify cells and compare expression levels of relevant receptors and cytokines.

Results: Egress of CFSE labeled T cells was significantly impaired in B6 IMQ mice relative to healthy controls. T cell S1PR1 expression was downregulated, suggesting that there is a high S1P level in the LN. Egress of CD69 KO T cells was also impaired and their S1PR1 expression was downregulated, further supporting that high S1P levels lead to the S1PR1 downregulation. CCL21+ fibroblast reticular cells (FRCs) significantly increased in B6 IMQ LNs, suggesting they are also acting as retention signals.

Conclusion: Here our results suggest two changes in the LN microenvironment, an increase in S1P levels and expansion of CCl21+ FRCs, that can promote increased retention of T cells. Current directions are focused on understanding what regulates these changes and what their impact on T cell phenotype is. As impaired egress of T cells can potentially contribute to disease pathogenesis, understanding what regulates T cell exit may potentially open a new area of therapeutic advancement in SLE.


Disclosures: M. Howlader, None; A. Baeyens, None; S. Schwab, None; t. Lu, None.

To cite this abstract in AMA style:

Howlader M, Baeyens A, Schwab S, Lu t. The Lymph Node Microenvironment in SLE Mice Is Altered and Impairs Egress of T Lymphocytes [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/the-lymph-node-microenvironment-in-sle-mice-is-altered-and-impairs-egress-of-t-lymphocytes/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-lymph-node-microenvironment-in-sle-mice-is-altered-and-impairs-egress-of-t-lymphocytes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology